Belgium
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
24.30%
|
Dec. 31, 2023 | USD 193.31 | -0.57% |
|
Belgium |
|
2 |
18.45%
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
|
3 |
17.58%
|
Dec. 31, 2023 | USD 20.10 | 1.93% |
|
Belgium |
|
4 |
-43.41%
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
5 |
-967.80%
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
6 |
-4,091.26%
|
Dec. 31, 2023 | USD 2.20 | -1.56% |
|
Belgium |
The Healthcare company in Belgium with the highest EBITDA Margin is UCB SA (Brussels Stock Exchange: UCB.BR) at 24.30%.
The Healthcare company in Belgium with the lowest EBITDA Margin is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at -4,091.26%.
The top 10 Healthcare companies in Belgium by EBITDA Margin are UCB SA, Galapagos NV, Fagron NV, MDxHealth SA, Nyxoah S.A. and Sequana Medical NV.
The bottom 10 Healthcare companies in Belgium by EBITDA Margin are Sequana Medical NV, Nyxoah S.A., MDxHealth SA, Fagron NV, Galapagos NV and UCB SA.